©The Author(s) 2025.
World J Crit Care Med. Dec 9, 2025; 14(4): 103782
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.103782
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.103782
Table 6 Friedman test results for the changes in Karnofsky Performance Scale Values of patients before and after the intervention
| n | Mean | SD | Mean rank | χ2 | df | P value | |
| Preoperative | 5 | 46.00 | 11.402 | 1.80 | 23.526 | 5 | 0.000 |
| Postoperative 1st week | 5 | 46.00 | 11.402 | 1.80 | |||
| Postoperative 1st month | 5 | 50.00 | 7.071 | 2.50 | |||
| Postoperative 2nd month | 5 | 60.00 | 12.247 | 4.10 | |||
| Postoperative 4th month | 5 | 66.00 | 11.402 | 5.00 | |||
| Postoperative 12th month | 5 | 72.00 | 8.367 | 5.80 |
- Citation: Kabatas S, Civelek E, Savrunlu EC, Kaplan N, Akkoc T, Küçükçakır N, Bozkurt M, Karaöz E. Efficacy and safety of exosomes from Wharton’s Jelly-derived mesenchymal stem cells in traumatic brain injury. World J Crit Care Med 2025; 14(4): 103782
- URL: https://www.wjgnet.com/2220-3141/full/v14/i4/103782.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v14.i4.103782